Remepy
Pioneering Hybrid Drugs
Remepy develops "hybrid drugs" that combine traditional pharmaceutical medicines with personalized, AI-driven digital software applications delivered via mobile apps. These integrated digital protocols target motor, cognitive, and mental functions to work synergistically with the active drug ingredients and enhance overall treatment effectiveness. Remepy is backed by experienced tech and biotech investors, including M Ventures, O.G. Venture Partners, NFX, TechAviv, Vine Ventures, Qumra Capital, and others.
